James Delmore Shapely had come to the attention of the AIDS industry in the early months of the new century. He was thirty-one years old, a prostitute, and had been HIV-positive for twelve years. At the time of his "discovery," by Dr. Kim Kutnik of Atlanta, Georgia, Shapely was serving a two hundred and fifty day prison term for soliciting. (His status as HIV-positive, which would automatically have warranted more serious charges, had apparently been "glitched.") Kutnik, a researcher with the Sharman Group, an American subsidiary of Shibata Pharmaceuticals, was sifting prison medical data in search of individuals who had been HIV-positive for a decade or more, were asymptomatic, and had entirely normal (or, as in Shapely’s case, above the norm) T-cell counts.